met the diagnostic criteria of CAP confirmed by pneumonia symptoms such as cough, change/purulence of sputum color, fever, or breathlessness had pneumonia sign by chest X-ray (infiltrate of pneumonia). community acquired pneumonia Zingiber officinale var rubrum inflammatory marker length of hospitalization
Conditions
Interventions
In treatment group, the patients received oral Z. officinale capsule 300 mg daily for five days as well as CAP standard therapy. ,In the control group, the patient received CAP standard therapy
Experimental Drug,No Intervention Drug
Sponsors
Indonesia Non (state budget) APBN funds of research institutions and community service
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. met the diagnostic criteria of CAP 2. confirmed by pneumonia symptoms such as cough, change/purulence of sputum color, fever, or breathlessness 3. had pneumonia sign by chest X-ray (infiltrate of pneumonia).
Exclusion criteria
Exclusion criteria: 1. severe CAP 2. having cardiopulmonary failure 3. physical disfunction who could not complete the study 4. patients with mental or communication disorder were excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL-6 5 days after intervention IL-6 Human ELISA kit (DE2132) quantitative assay,PCT 5 days after intervention PCT Human ELISA kit (E-EL-H1492) quantitative assay,NLR 5 days after intervention leukocyte diffcount examination by using a blood smear and be counted manually (Neubauer) | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of stay 5 days after intervention Total days from admission until discharge date | — |
Countries
Indonesia
Contacts
Public ContactBrigitta Devi Hapsari
Medical Faculty Sebelas Maret University
Outcome results
None listed